The proceeds will be mainly used to its R&D advancement.
Carbon Med recently annouced its completion of the pre-Series A financing round valued at tens of millions of CNY.
This round was led by Jinding Capital and Shenzhen Zhongxiao. The funding will be used for the channel construction of its new medical products, R&D of new projects, clinilcal support and team building.
Founded in April 2018, Carbon Medical is specialized in the field of non-vascular interventional therapy. Leveraging its image fusion ultrasound platform technology, Carbon Medical provides a full set of equipment and surgical supplies for urology, hepatobiliary surgery, rehabilitation department and other surgical departments.